Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Detoxil effectively treats chronic skin conditions by improving liver detoxification and reducing symptoms.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Quercetin and kaempferol may be effective and safe natural treatments for hair loss.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Adapalene, Diosmin, and Azelastine may effectively treat onchocerciasis.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Blocking JAK-STAT signaling can lead to hair growth.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.